Stay updated on PDR001 with Chemo and Immunology Agents in NSCLC Clinical Trial

Sign up to get notified when there's something new on the PDR001 with Chemo and Immunology Agents in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the PDR001 with Chemo and Immunology Agents in NSCLC Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    A minor revision update from v3.3.3 to v3.3.4 is shown, with no substantive changes to the page content.
    Difference
    0.0%
    Check dated 2026-01-14T02:28:00.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    Added location listings for multiple regions (Arkansas, California, Michigan, Missouri, Ontario, Hong Kong, FC, MI, PN, Catalonia) and updated the revision to v3.3.3; removed the HHS Vulnerability Disclosure link and related location sections.
    Difference
    0.9%
    Check dated 2025-12-23T12:47:09.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    Page revision updated from v3.3.1 to v3.3.2. No substantive study details or user-facing content appear to be changed.
    Difference
    0.0%
    Check dated 2025-12-01T17:59:28.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    Publications note updated to indicate items are automatically filled from PubMed and may not relate to the study; page revision updated to v3.3.1.
    Difference
    0.1%
    Check dated 2025-11-24T14:46:29.000Z thumbnail image
  7. Check
    61 days ago
    Change Detected
    Summary
    A government funding status notice was removed from the page. The study details themselves appear unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-17T07:15:20.000Z thumbnail image
  8. Check
    75 days ago
    Change Detected
    Summary
    Two screenshots show only minor UI/formatting differences with no changes to study details, eligibility criteria, or interventions. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-03T01:22:19.000Z thumbnail image

Stay in the know with updates to PDR001 with Chemo and Immunology Agents in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the PDR001 with Chemo and Immunology Agents in NSCLC Clinical Trial page.